Atom Therapeutics
PrivateLast Round
Series D
Oct 16, 2023
Est. Valuation
$430M
Total Funding Raised
$158M
Company Overview
Atom Therapeutics operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series D round in October 2023.
Atom Therapeutics is a clinical-stage biotechnology company that develops novel oral small molecule therapeutics for the treatment of inflammatory, metabolic, and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atom Therapeutics Comparables
Compare Atom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InventisBio | 84% | |
| Evopoint Biosciences | 83% | |
| Crystalys Therapeutics | 83% |
For institutional investors. Book with your work email.
Atom Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 16, 2023 | ||||
| Series C | Jan 5, 2022 | ||||
| Series B | May 29, 2020 |
For institutional investors. Book with your work email.
Atom Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series C |
| Kaitai Capital | Series B, Series C, Series D |
| 新毅投资 | Series D |
| Shenzhen Dachen Caizhi Venture Capital Management | Series D |
| Efung Capital | Series C |
| Shenzhen GTJA Investment Group | Series C |
| HongShan Capital Group (HSG) | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2023
$83M round led by Kaitai Capital.
- Jan 5, 2022
$45M round led by Shenzhen GTJA Investment Group.
For institutional investors. Book with your work email.
Atom Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atom Therapeutics's valuation, stock price, and market status.
Is Atom Therapeutics a public or private company?
Atom Therapeutics is a private company.
What is the current stock price of Atom Therapeutics?
Atom Therapeutics is a private company, so its shares have no public market price. Caplight tracks Atom Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atom Therapeutics worth (valuation)?
Atom Therapeutics's valuation is estimated at $430.0M based on funding round data.
Can I buy Atom Therapeutics stock?
Atom Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atom Therapeutics's last funding round?
Atom Therapeutics's most recent funding round was Series D on October 16, 2023.
Who are the main investors in Atom Therapeutics?
Key investors in Atom Therapeutics include Kaitai Capital, Shenzhen GTJA Investment Group, HongShan Capital Group (HSG).
Will Atom Therapeutics IPO soon?
No public IPO plans have been announced for Atom Therapeutics.
How can I track Atom Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Atom Therapeutics's shares on secondary markets.